As of 2025-03-20, the Relative Valuation of Aligos Therapeutics Inc (ALGS) is (342.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.76 USD, the upside of Aligos Therapeutics Inc based on Relative Valuation is -3281.1%.
The range of the Relative Valuation is (213.31) - (498.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 26.7x | 16.5x |
| Forward P/E multiples | 9.3x - 23.2x | 15.4x |
| Fair Price | (213.31) - (498.72) | (342.28) |
| Upside | -2082.4% - -4735.0% | -3281.1% |
| Date | P/E |
| 2025-03-04 | -0.64 |
| 2025-03-03 | -0.68 |
| 2025-02-28 | -0.79 |
| 2025-02-27 | -0.78 |
| 2025-02-26 | -0.83 |
| 2025-02-25 | -0.81 |
| 2025-02-24 | -0.83 |
| 2025-02-21 | -0.87 |
| 2025-02-20 | -0.97 |
| 2025-02-19 | -1.04 |
| 2025-02-18 | -1.06 |
| 2025-02-14 | -1.10 |
| 2025-02-13 | -0.98 |
| 2025-02-12 | -0.98 |
| 2025-02-11 | -1.21 |
| 2025-02-10 | -1.29 |
| 2025-02-07 | -1.28 |
| 2025-02-06 | -1.28 |
| 2025-02-05 | -1.18 |
| 2025-02-04 | -1.21 |
| 2025-02-03 | -1.05 |
| 2025-01-31 | -1.20 |
| 2025-01-30 | -1.11 |
| 2025-01-29 | -1.12 |
| 2025-01-28 | -1.15 |
| 2025-01-27 | -1.20 |
| 2025-01-24 | -1.42 |
| 2025-01-23 | -1.49 |
| 2025-01-22 | -1.53 |
| 2025-01-21 | -1.57 |
| 2025-01-17 | -1.60 |
| 2025-01-16 | -1.47 |
| 2025-01-15 | -1.48 |
| 2025-01-14 | -1.40 |
| 2025-01-13 | -1.60 |
| 2025-01-10 | -1.57 |
| 2025-01-08 | -1.79 |
| 2025-01-07 | -1.91 |
| 2025-01-06 | -2.13 |
| 2025-01-03 | -2.02 |
| 2025-01-02 | -1.86 |
| 2024-12-31 | -1.86 |
| 2024-12-30 | -1.89 |
| 2024-12-27 | -1.92 |
| 2024-12-26 | -2.02 |
| 2024-12-24 | -1.83 |
| 2024-12-23 | -1.81 |
| 2024-12-20 | -1.86 |
| 2024-12-19 | -1.79 |
| 2024-12-18 | -1.54 |